Science Explorer Interactive view Map
Company · New Brunswick · United States

Johnson & Johnson (United States)

In research, Johnson & Johnson (United States) stands highest in Medicine (#1,951 of 10,443 worldwide), Health Sciences (#2,308 of 11,982 worldwide) and Life Sciences (#2,294 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology and Immunology — Hematology is 9.7× its share of world research.

jnj.comROR OpenAlex
World rank, 2022–2025
#4,112
of 28,054 · #2,076 all time
Rank in United States
#576
of 4,192
Research works
6.1k
▲ 38% vs 2013–17
Citations
192k
31.7 per fractional work
Top-10% rate
15.9%
record average 16.5%
Open access
31%
world 28%

What is Johnson & Johnson (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #1,951 of 10,443 16.5%410 #994
Health SciencesDomain #2,308 of 11,982 16.7%443 #1024
Life SciencesDomain #2,294 of 7,800 14.4%129 #1122
Physical SciencesDomain #7,275 of 12,888 15.1%110 #4632
Social SciencesDomain #7,255 of 10,521 14.7%87 #3627
Biochemistry, Genetics and Molecular BiologyField #3,202 of 3,579 14.7%66 #1555

Each strip is that field’s whole ranked pool, with the notch where Johnson & Johnson (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#994 #1,951
  2. Health Sciences#1,024 #2,308
  3. Life Sciences#1,122 #2,294
  4. Physical Sciences#4,632 #7,275
  5. Social Sciences#3,627 #7,255
  6. Biochemistry, Genetics and Molecular Biology#1,555 #3,202
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Johnson & Johnson (United States) specialise in?

Where its research is concentrated relative to its size: Hematology takes 9.7× the share of its output that it takes of world research.

  1. HematologySubfield · 22.5 works9.7×
  2. ImmunologySubfield · 25.2 works4.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 6 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.62× its world share, 66 worksBiochemistry, Geneti…Immunology and Microbiology: 3.91× its world share, 30 worksImmunology and Micro…Neuroscience: 1.15× its world share, 14 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.43× its world share, 12 worksPharmacology, Toxico…Chemical Engineering: 0.14× its world share, 0 worksChemical EngineeringChemistry: 1.28× its world share, 16 worksChemistryComputer Science: 0.25× its world share, 15 worksComputer ScienceEarth and Planetary Sciences: 0.12× its world share, 1 worksEarth and Planetary …Energy: 0.01× its world share, 0 worksEnergyEngineering: 0.34× its world share, 39 worksEngineeringEnvironmental Science: 0.34× its world share, 13 worksEnvironmental ScienceMaterials Science: 0.44× its world share, 12 worksMaterials ScienceMathematics: 1.35× its world share, 12 worksMathematicsPhysics and Astronomy: 0.12× its world share, 2 worksPhysics and AstronomyDentistry: 0.89× its world share, 3 worksDentistryHealth Professions: 1.14× its world share, 23 worksHealth ProfessionsMedicine: 2.78× its world share, 410 worksMedicineNursing: 0.70× its world share, 3 worksNursingVeterinary: 3.64× its world share, 4 worksVeterinaryArts and Humanities: 0.26× its world share, 6 worksArts and HumanitiesBusiness, Management and Accounting: 0.32× its world share, 8 worksBusiness, Management…Decision Sciences: 0.98× its world share, 7 worksDecision SciencesEconomics, Econometrics and Finance: 1.81× its world share, 30 worksEconomics, Econometr…Psychology: 0.79× its world share, 18 worksPsychologySocial Sciences: 0.19× its world share, 18 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.4×. Every wedge is a field page.

Who are the top researchers at Johnson & Johnson (United States)?

Ranked on the composite score, Bruce E. Maryanoff, Nikiforos Kollias and Paul Stang lead among researchers whose main affiliation is Johnson & Johnson (United States).

  1. 1 Bruce E. Maryanoff United States · #15,927 worldwide 795 citations · 60 works
  2. 2 Nikiforos Kollias United States · #114,172 worldwide 289 citations · 34 works
  3. 3 Paul Stang United States · #201,906 worldwide 200 citations · 19 works
  4. 4 Peter J. Connolly United States · #246,288 worldwide 41 citations · 26 works
  5. 5 Lars Karlsson United States · #252,586 worldwide 141 citations · 22 works
  6. 6 Patricia Andrade‐Gordon United States · #262,328 worldwide 151 citations · 19 works
  7. 7 Naidong Weng United States · #272,766 worldwide 107 citations · 19 works
  8. 8 David C. Palmer United States · #273,675 worldwide 87 citations · 18 works
  9. 9 Suzanne Hall Johnson United States · #326,101 worldwide 22 citations · 31 works
  10. 10 Changlu Liu United States · #349,744 worldwide 101 citations · 18 works
All ranked researchers at Johnson & Johnson (United States)

Which keywords describe research at Johnson & Johnson (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Guidelines, Immunotherapy, Clinical Trials, Chemotherapy, Inflammatory Cytokines, Inflammation and Quality of Life.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology65▲ 2.1×90 topics
  2. Inflammation31▲ 1.95×65 topics
  3. Quality of Life27▲ 2.4×36 topics
  4. Guidelines26▲ 7.4×12 topics
  5. Oxidative Stress26▲ 2.1×38 topics
  6. Immunotherapy26▲ 4.7×18 topics
  7. Clinical Trials22▲ 4.3×16 topics
  8. Chemotherapy22▲ 4.1×20 topics
  9. Biomarkers20▲ 3.8×15 topics
  10. Treatment20▲ 2.2×26 topics
  11. Inflammatory Cytokines16▲ 25×3 topics
  12. Monoclonal Antibodies15▲ 22×3 topics
  13. Autoantibodies14▲ 8.0×8 topics
  14. Complications14▲ 3.7×13 topics
  15. Cost-effectiveness Analysis14▲ 22×1 topic
  16. Economic Evaluation14▲ 15×2 topics
  17. Health Utility Measures14▲ 22×1 topic
  18. Mortality14▲ 3.1×12 topics
  19. Treatment Guidelines14▲ 8.3×5 topics
  20. Catheter Ablation14▲ 15×2 topics
  21. Minimal Residual Disease13▲ 24×2 topics
  22. Targeted Therapy12▲ 7.3×5 topics
  23. Proteasome Inhibitors12▲ 22×2 topics
  24. Staging System12▲ 25×2 topics
  25. Diagnosis Criteria12▲ 43×1 topic
  26. International Myeloma Working Group12▲ 43×1 topic
  27. Clinical Guidelines12▲ 5.2×9 topics
  28. Clinical Outcomes12▲ 7.0×6 topics
  29. Immune System10▲ 5.5×6 topics
  30. TGF-ß10▲ 8.5×4 topics
  31. Lymphoma10▲ 7.9×4 topics
  32. Anticoagulant Therapy10▲ 10×3 topics
  33. Genomic Profiling10▲ 12×2 topics
  34. Therapeutic Antibodies10▲ 18×2 topics
  35. Cancer Immunotherapy10▲ 8.1×3 topics
  36. Glycosylation9▲ 11×3 topics
  37. Revision Surgery9▲ 9.4×2 topics
  38. Total Hip Replacement9▲ 9.4×2 topics
  39. Stroke Prevention9▲ 9.8×2 topics
  40. Atrial Fibrillation9▲ 12×2 topics

Which research topics does Johnson & Johnson (United States) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Multiple Myeloma Research and Treatments, Atrial Fibrillation Management and Outcomes and Ophthalmology and Visual Impairment Studies.

Health Systems, Economic…14Health Systems, Economic Evaluations, Quality of Life: 14 fractional worksMultiple Myeloma Researc…12Multiple Myeloma Research and Treatments: 12 fractional worksAtrial Fibrillation Management and Outcomes: 8 fractional worksOphthalmology and Visual Impairment Studies: 8 fractional worksOcular Surface and Contact Lens: 8 fractional worksPsoriasis: Treatment and Pathogenesis: 8 fractional worksCAR-T cell therapy resea…7CAR-T cell therapy research: 7 fractional worksSkin Protection and Aging: 7 fractional worksMonoclonal and Polyclonal Antibodies Research: 6 fractional worksLung Cancer Treatments a…6Lung Cancer Treatments and Mutations: 6 fractional works
Economics and EconometricsHematologyCardiology and Cardiovascular MedicineEpidemiology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 14 works
  2. 2 Multiple Myeloma Research and Treatments Hematology 12 works
  3. 3 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 8 works
  4. 4 Ophthalmology and Visual Impairment Studies Epidemiology 8 works
  5. 5 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 8 works
  6. 6 Psoriasis: Treatment and Pathogenesis Immunology 8 works
  7. 7 CAR-T cell therapy research Oncology 7 works
  8. 8 Skin Protection and Aging Dermatology 7 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
  10. 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.8%not open69.2%

World: 28% of research is openly available.

with international co-authors20.8%domestic only79.2%

World: 19% is written across borders.

How has Johnson & Johnson (United States)'s research output changed?

Output in 2018–2022 was 38% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New Brunswick

All research institutions in New Brunswick

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.